Atorvastatin: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
===[[Atorvastatin calcium]]=== | ===[[Atorvastatin calcium]] ([[Atorvastatin calcium|Lipitor]])=== | ||
===[[Amlodipine besylate/Atorvastatin calcium]]=== | ===[[Amlodipine besylate/Atorvastatin calcium]]=== | ||
===[[Amlodipine/Atorvastatin]]=== | ===[[Amlodipine/Atorvastatin]]=== | ||
| Line 9: | Line 9: | ||
==Overview== | ==Overview== | ||
Sandbox Atorvastatin is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease | Sandbox Atorvastatin is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease. Adverse reactions include [[diarrhea]], [[arthralgia]], [[myalgia]], urinary tract infectious disease, [[nasopharyngitis]], pain, in extremity. | ||
==Category== | ==Category== | ||
HMG-COA Reductase Inhibitor | HMG-COA Reductase Inhibitor | ||
Revision as of 14:02, 20 June 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Atorvastatin calcium (Lipitor)
Amlodipine besylate/Atorvastatin calcium
Amlodipine/Atorvastatin
Ezetimibe/Atorvastatin
Overview
Sandbox Atorvastatin is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease. Adverse reactions include diarrhea, arthralgia, myalgia, urinary tract infectious disease, nasopharyngitis, pain, in extremity.
Category
HMG-COA Reductase Inhibitor